| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 3,750 | $30 | $123.8K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,800 | $30 | $98.8K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 6,280 | $10 | $62.8K |
| J3262 | Injection, tocilizumab, 1 mg | 8,400 | $10 | $42K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 440 | $80 | $33.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 100 | $120 | $11.7K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 160 | $60 | $9.5K |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | 840 | $10 | $9.2K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 50 | $110 | $5.3K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 70 | $30 | $1.8K |